Insulin sensitizers–drugs that increase sensitivity to insulin such as Avandia and Actos–could help lessen the risk of peripheral arterial disease (PAD) for those with type 2 diabetes, according to a new study.
Read more
DiabetesHealth – TII Diabetes Patients on Insulin Sensitizers Run Lower PAD Risk